• Mashup Score: 0

    Goldsmith SR, Abid MB, Auletta JJ, et al. Posttransplant Cyclophosphamide Is Associated With Increased Cytomegalovirus Infection: A CIBMTR Analysis. Blood. 2021; 137 (23) (doi: 10.1182/blood.2020009362). An analysis of patients reported to the Center for International Blood and Marrow Transplantation Research between 2012 and 2017 found that post-transplant cyclophosphamide (PTCy) elevated the…

    Tweet Tweets with this article
    • New on Nucleus: "CMV-seropositive recipients had the highest CMV infection risk; however, the risk was much higher among patients who received PTCy, regardless of donor." #CMV #transplantation #PTCy https://t.co/AmT9HsUpdf https://t.co/Sy9YJWDiBl